skip to: main content | section menu | full site menu

Technology Transfer from the University of Oxford

Licensing Opportunities

Pharmaceutical

The following technologies are available for licensing in this group:

Technology Updates

In order to keep in touch with people and organisations interested in Isis' technologies, we provide regular email updates on new technologies. Request Technology Updates.

Project number 66 - Chiral Peptide Nucleic Acids

Project number 957 - Controlled Drug Release

Project number 1288 - Improved Viral Vectors for Gene Therapy and Vaccination

Project number 1428 - Improved Vaccination Using Lentivirus in Prime/Boost Protocols

Project number 1441 - CDK2/Cyclin A

Project number 1538 - Comprehensive Meningococcal Vaccine

Project number 2452 - Recombinant Overlapping Peptide Vaccines for Infectious Disease and Cancer

Project number 2791 - Transfection Reagent Adjuvant

Project number 2805 - DNA Nanotetrahedra for Drug Delivery

Project number 2816 - Allergen Specific T-cell Clones for Antibody testing

Project number 2932 - Molecular Shape Recognition

Project number 2944 - Antagonist to the NAADP Receptor

Project number 3050 - Anti-Inflammatory Treatment

Project number 3101 - A Novel Cancer Biomarker and Drug Target

Project number 3265 - Use of calcium modulators and miglustat in NPC

Project number 3310 - High Density Protein Nanoarray

Project number 3329 - High-Throughput Screening Of Membrane Proteins

Project number 3337 - HLA Typing

Project number 3360 - MVA NP + M1 Influenza Vaccine

Project number 3479 - AdCh63 ME.TRAP Malaria Vaccine

Project number 3491 - Novel Vaccine Ajuvants-CCR4 Antagonists

Project number 3507 - Oxford Genome-wide Association Software Suite

Project number 3542 - Biomarker For Improving Statin Therapy

Project number 3558 - Carbopol as an Adjuvant

Project number 3579 - Improved Drug Target Characterisation and Screening

Project number 3593 - A Novel Method For The Treatment Of Obesity

Project number 3644 - Treatment of Heart Failure

Project number 3645 - Using MicroRNA to Create Ultra-specific Viral Vaccines

Project number 3715 - Clinical Diagnosis and Drug Screening for Lysosomal Diseases

Project number 3776 - Novel Method for Enhancing Protein Yields in the Lab and in Large Scale Manufacture

Project number 3825 - New Target for Regulating Intracellular Calcium Signalling

Project number 3849 - Quantitative Screening Assay For Protein Surface Changes

Project number 3875 - Modified Anti-CD40L Antibody Induces Long-Term Tolerance

Project number 3948 - Antibiotic Nanomaterial

Project number 3991 - Prime/Boost Vaccination using a Mixed Vector Approach

Project number 4096 - Novel RNAi Delivery Technology

Project number 4098 - Improved Steroid Treatment

Project number 4203 - Novel Bisphosphonate Compounds

Project number 4258 - Ultra-Stable Streptavidin

Project number 70510 - Delivery Technology for Intestinal Drugs

Project number 70514 - New Technology for Gene Delivery and Vaccines

Project number 70640 - Drug Carrier for Treatment of Cancer

Project number 71223 - Detection of Low Affinity TCRs

Project number 71531 - Higher Yields of Therapeutic Protein Products

Project number 73004 - Nano and Micro-technology for Gene Delivery

Project number 74001 - Improved Synthetic Pulmonary Surfactant

Project number 74002 - Improved Protein Manufacturing Platform

Project number 74003 - New Glaucoma Treatment

Project number 74005 - Biomarker for Oesophageal Cancer

Project number 74010 - Improved Vaccine Formulation